BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31562641)

  • 1. Transcriptional downregulation of miR-127-3p by CTCF promotes prostate cancer bone metastasis by targeting PSMB5.
    Fan J; Du W; Zhang H; Wang Y; Li K; Meng Y; Wang J
    FEBS Lett; 2020 Feb; 594(3):466-476. PubMed ID: 31562641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
    Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
    J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
    Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
    Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
    J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling.
    Huang S; Wa Q; Pan J; Peng X; Ren D; Li Q; Dai Y; Yang Q; Huang Y; Zhang X; Zhou W; Yuan D; Cao J; Li Y; He P; Tang Y
    Cell Death Dis; 2018 Jul; 9(7):779. PubMed ID: 30006541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
    Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin inhibits proteasome activity in triple-negative breast cancer cells through regulating p300/miR-142-3p/PSMB5 axis.
    Liu L; Fu Y; Zheng Y; Ma M; Wang C
    Phytomedicine; 2020 Nov; 78():153312. PubMed ID: 32866906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTCF-induced upregulation of HOXA11-AS facilitates cell proliferation and migration by targeting miR-518b/ACTN4 axis in prostate cancer.
    Xing Z; Li S; Liu Z; Zhang C; Bai Z
    Prostate; 2020 Apr; 80(5):388-398. PubMed ID: 31971633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
    Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
    Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
    [No Abstract]   [Full Text] [Related]  

  • 10. The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.
    Dai Y; Ren D; Yang Q; Cui Y; Guo W; Lai Y; Du H; Lin C; Li J; Song L; Peng X
    Br J Cancer; 2017 Aug; 117(5):685-694. PubMed ID: 28697177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
    Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer.
    Hu CY; Chen J; Qin XH; You P; Ma J; Zhang J; Zhang H; Xu JD
    J Exp Clin Cancer Res; 2021 Mar; 40(1):98. PubMed ID: 33722248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer.
    Xia L; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W; Sha J
    Biomed Pharmacother; 2020 Apr; 124():109863. PubMed ID: 31986411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling.
    Li Q; Ye L; Zhang X; Wang M; Lin C; Huang S; Guo W; Lai Y; Du H; Li J; Song L; Peng X
    Cancer Lett; 2017 Aug; 402():166-176. PubMed ID: 28602974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment.
    Qu Y; Huang X; Li Z; Liu J; Wu J; Chen D; Zhao F; Mu D
    Am J Pathol; 2014 May; 184(5):1541-9. PubMed ID: 24631181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis.
    Zhu Z; Wen Y; Xuan C; Chen Q; Xiang Q; Wang J; Liu Y; Luo L; Zhao S; Deng Y; Zhao Z
    FEBS Open Bio; 2020 Apr; 10(4):674-688. PubMed ID: 32027093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4.
    Hu CY; You P; Zhang J; Zhang H; Jiang N
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5133-5138. PubMed ID: 31298366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-15a-3p Suppresses Prostate Cancer Cell Proliferation and Invasion by Targeting SLC39A7 Via Downregulating Wnt/β-Catenin Signaling Pathway.
    Cui Y; Yang Y; Ren L; Yang J; Wang B; Xing T; Chen H; Chen M
    Cancer Biother Radiopharm; 2019 Sep; 34(7):472-479. PubMed ID: 31135177
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
    Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
    Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.